Biochemical characterization of Mycobacterium tuberculosis dihydroorotate dehydrogenase and identification of a selective inhibitor

被引:2
|
作者
Alberti, Marta [1 ]
Sainas, Stefano [2 ]
Ronchi, Erika [1 ]
Lolli, Marco L. [2 ]
Boschi, Donatella [2 ]
Rizzi, Menico [1 ]
Ferraris, Davide M. [1 ]
Miggiano, Riccardo [1 ,3 ]
机构
[1] Univ Piemonte Orientale, Dept Pharmaceut Sci, Novara, Italy
[2] Univ Turin, Dept Sci & Drug Technol, Turin, Italy
[3] Univ Piemonte Orientale, Dept Pharmaceut Sci, Via Bovio 6, I-28100 Novara, Italy
关键词
dihydroorotate dehydrogenase; drug discovery; Mycobacterium tuberculosis; pyrimidine biosynthesis; tuberculosis; SCAFFOLD SAR; VIRULENCE; GROWTH;
D O I
10.1002/1873-3468.14680
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Mycobacterium tuberculosis (MTB) is the etiologic agent of tuberculosis (TB), an ancient disease which causes 1.5 million deaths worldwide. Dihydroorotate dehydrogenase (DHODH) is a key enzyme of the MTB de novo pyrimidine biosynthesis pathway, and it is essential for MTB growth in vitro, hence representing a promising drug target. We present: (i) the biochemical characterization of the full-length MTB DHODH, including the analysis of the kinetic parameters, and (ii) the previously unreleased crystal structure of the protein that allowed us to rationally screen our in-house chemical library and identify the first selective inhibitor of mycobacterial DHODH. The inhibitor has fluorescence properties, potentially instrumental to in cellulo imaging studies, and exhibits an IC50 value of 43 mu M, paving the way to hit-to-lead process.
引用
收藏
页码:2119 / 2132
页数:14
相关论文
共 50 条
  • [1] Biochemical characterization and structural insights into Mycobacterium tuberculosis dihydroorotate dehydrogenase as innovative therapeutic target
    Alberti, M.
    Sainas, S.
    Boschi, D.
    Ferraris, D.
    Ronchi, E.
    Pollastro, F.
    Lolli, M.
    Rizzi, M.
    Miggiano, R.
    FEBS OPEN BIO, 2024, 14 : 207 - 207
  • [2] Mycobacterium tuberculosis histidinol dehydrogenase: biochemical characterization and inhibition studies
    Lunardi, Juleane
    Borges Martinelli, Leonardo Kras
    Raupp, Alessandra Silva
    Sacconi Nunes, Jose Eduardo
    Rostirolla, Diana Carolina
    Saraiva Macedo Timmers, Luis Fernando
    Villela, Anne Drumond
    Pissinate, Kenia
    Limberger, Jones
    de Souza, Osmar Norberto
    Basso, Luiz Augusto
    Santos, Diogenes Santiago
    Machado, Pablo
    RSC ADVANCES, 2016, 6 (34) : 28406 - 28418
  • [3] Identification of dihydroorotate dehydrogenase inhibitor, vidofludimus, as a potent and novel inhibitor for influenza virus
    Li, Jiazhou
    Takeda, Midori
    Imahatakenaka, Mikiko
    Ikeda, Masanori
    JOURNAL OF MEDICAL VIROLOGY, 2024, 96 (01)
  • [4] Biochemical characterization of the heteromeric Bacillus subtilis dihydroorotate dehydrogenase and its isolated subunits
    Kahler, AE
    Nielsen, FS
    Switzer, RL
    ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1999, 371 (02) : 191 - 201
  • [5] Identification of a novel inhibitor (NSC 665564) of dihydroorotate dehydrogenase with a potency equivalent to brequinar
    Cleaveland, ES
    Zaharevitz, DW
    Kelley, JA
    Paull, K
    Cooney, DA
    Ford, H
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1996, 223 (03) : 654 - 659
  • [6] Identification of a dihydroorotate dehydrogenase inhibitor that inhibits cancer cell growth by proteomic profiling
    Kawatani, Makoto
    Aono, Harumi
    Hiranuma, Sayoko
    Shimizu, Takeshi
    Muroi, Makoto
    Nogawa, Toshihiko
    Ohishi, Tomokazu
    Ohba, Shun-ichi
    Kawada, Manabu
    Yamazaki, Kanami
    Dan, Shingo
    Dohmae, Naoshi
    Osada, Hiroyuki
    ONCOLOGY RESEARCH, 2023, 31 (06) : 833 - 844
  • [7] Identification and Characterization of Small Molecule Inhibitors of Plasmodium falciparum Dihydroorotate Dehydrogenase
    Patel, Vishal
    Booker, Michael
    Kramer, Martin
    Ross, Leila
    Celatka, Cassandra A.
    Kennedy, Leah M.
    Dvorin, Jeffrey D.
    Duraisingh, Manoj T.
    Sliz, Piotr
    Wirth, Dyann F.
    Clardy, Jon
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2008, 283 (50) : 35078 - 35085
  • [8] BAY 2402234: A novel, selective dihydroorotate dehydrogenase (DHODH) inhibitor for the treatment of myeloid malignancies
    Janzer, Andreas
    Gradl, Stefan
    Christian, Sven
    Zimmermann, Katja
    Merz, Claudia
    Meyer, Hanna
    Stellfeld, Timo
    Guenther, Judith
    Stoeckigt, Detlef
    Seidel, Henrik
    Lejeune, Pascale
    Bruening, Michael
    Eheim, Ashley
    Mueller, Thomas
    Lesche, Ralf
    Michels, Martin
    Haegebarth, Andrea
    Bauser, Marcus
    El Sheikh, Sherif
    Ferrara, Steven
    Sykes, David
    Scadden, David
    CANCER RESEARCH, 2018, 78 (13)
  • [9] Identification of Human Dihydroorotate Dehydrogenase Inhibitor by a Pharmacophore-Based Virtual Screening Study
    Galati, Salvatore
    Sainas, Stefano
    Giorgis, Marta
    Boschi, Donatella
    Lolli, Marco L.
    Ortore, Gabriella
    Poli, Giulio
    Tuccinardi, Tiziano
    MOLECULES, 2022, 27 (12):
  • [10] Biochemical characterization of Mycobacterium tuberculosis IMP dehydrogenase: kinetic mechanism, metal activation and evidence of a cooperative system
    Rostirolla, Diana Carolina
    de Assuncao, Thiago Milech
    Bizarro, Cristiano Valim
    Basso, Luiz Augusto
    Santos, Diogenes Santiago
    RSC ADVANCES, 2014, 4 (50): : 26271 - 26287